Facial pain with localized and widespread manifestations: separate pathways of vulnerability.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3808468)

Published in Pain on July 16, 2013

Authors

Gary D Slade1, Shad B Smith, Dmitri V Zaykin, Inna E Tchivileva, Dustin G Gibson, Anton Yuryev, Ilya Mazo, Eric Bair, Roger Fillingim, Richard Ohrbach, Joel Greenspan, William Maixner, Luda Diatchenko

Author Affiliations

1: Regional Center for Neurosensory Disorders, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Dental Ecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: gary_slade@dentistry.unc.edu.

Associated clinical trials:

Genetic Variants Associated With Low Back Pain and Their Response to Treatment With Duloxetine or Propranolol | NCT03364075

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

A global measure of perceived stress. J Health Soc Behav (1983) 56.90

The short-form McGill Pain Questionnaire. Pain (1987) 14.40

Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord (1992) 9.73

Truncated product method for combining P-values. Genet Epidemiol (2002) 7.07

Analysing biological pathways in genome-wide association studies. Nat Rev Genet (2010) 6.63

Pathway analysis by adaptive combination of P-values. Genet Epidemiol (2009) 4.48

Gene and pathway-based second-wave analysis of genome-wide association studies. Eur J Hum Genet (2010) 3.03

Using genome-wide pathway analysis to unravel the etiology of complex diseases. Genet Epidemiol (2009) 2.72

Idiopathic pain disorders--pathways of vulnerability. Pain (2006) 2.69

Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain (1977) 2.60

Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev (2006) 2.59

Genetic and environmental influences on migraine: a twin study across six countries. Twin Res (2003) 2.22

Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain (1998) 2.10

Influence of psychological factors on risk of temporomandibular disorders. J Dent Res (2007) 2.02

T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci (2009) 1.91

Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain. Pain (1995) 1.76

Evoked pain measures in fibromyalgia. Best Pract Res Clin Rheumatol (2003) 1.69

Pain associated with multiple sclerosis: systematic review and proposed classification. Pain (2007) 1.65

Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain (2011) 1.62

Combining p-values in large-scale genomics experiments. Pharm Stat (2007) 1.58

Temporomandibular joint and muscle disorder-type pain in U.S. adults: the National Health Interview Survey. J Orofac Pain (2008) 1.58

Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain (2011) 1.52

Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain (2011) 1.50

T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience (2004) 1.45

Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci (2010) 1.37

T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol (2006) 1.30

Serotonin is a directly-acting hyperalgesic agent in the rat. Neuroscience (1992) 1.22

Somatosensory profiles in subgroups of patients with myogenic temporomandibular disorders and Fibromyalgia Syndrome. Pain (2009) 1.17

Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness. Pain (2011) 1.03

Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla. Neuroscience (2010) 1.01

The efficacy of oral splints in the treatment of myofascial pain of the jaw muscles: a controlled clinical trial. Pain (1994) 1.01

Serotonin receptor 5-HT2B mediates serotonin-induced mechanical hyperalgesia. J Neurosci (2011) 0.97

Relationship between temporomandibular disorders, widespread palpation tenderness, and multiple pain conditions: a case-control study. J Pain (2012) 0.95

Quantification of changes in myofascial trigger point sensitivity with the pressure algometer following passive stretch. Pain (1986) 0.94

Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav (1992) 0.94

5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain (1998) 0.93

Summary of findings from the OPPERA baseline case-control study: implications and future directions. J Pain (2011) 0.92

Excess risk of temporomandibular disorder associated with cigarette smoking in young adults. J Pain (2011) 0.88

5-Hydroxytryptamine and antinociception. Neuropharmacology (1984) 0.88

Identifying undiagnosed rheumatic disorders among patients with TMD. J Am Dent Assoc (1997) 0.80

The role of serotonin in analgesia elicited by morphine in the periaqueductal gray matter (PAG). Brain Res (1991) 0.78

Articles by these authors

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48

Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A (2004) 10.99

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med (2004) 9.81

Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet (2004) 5.87

Social modulation of pain as evidence for empathy in mice. Science (2006) 5.32

Pathway studio--the analysis and navigation of molecular networks. Bioinformatics (2003) 4.27

Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache (2014) 4.25

Extracting human protein interactions from MEDLINE using a full-sentence parser. Bioinformatics (2004) 4.14

GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med (2006) 3.38

Research diagnostic criteria for temporomandibular disorders (RDC/TMD): development of image analysis criteria and examiner reliability for image analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 3.12

Selection of genetic markers for association analyses, using linkage disequilibrium and haplotypes. Am J Hum Genet (2003) 2.94

Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain (2006) 2.75

Idiopathic pain disorders--pathways of vulnerability. Pain (2006) 2.69

Perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis. Pain (2009) 2.55

Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain (2010) 2.41

A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene. Cell (2010) 2.37

Equilibrium free energies from nonequilibrium measurements using maximum-likelihood methods. Phys Rev Lett (2003) 2.30

Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. Nat Med (2012) 2.25

A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis (2012) 2.15

Methane oxidation by an extremely acidophilic bacterium of the phylum Verrucomicrobia. Nature (2007) 2.12

Binding properties and evolution of homodimers in protein-protein interaction networks. Nucleic Acids Res (2005) 2.10

Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood (2003) 2.05

The Research Diagnostic Criteria for Temporomandibular Disorders. V: methods used to establish and validate revised Axis I diagnostic algorithms. J Orofac Pain (2010) 2.00

Effect of two- and three-locus linkage disequilibrium on the power to detect marker/phenotype associations. Genetics (2004) 1.85

Multiple tests for genetic effects in association studies. Methods Mol Biol (2002) 1.85

Influence of genotype, dose and sex on pruritogen-induced scratching behavior in the mouse. Pain (2006) 1.83

A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82

Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A (2010) 1.79

Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain (2010) 1.79

The Research Diagnostic Criteria for Temporomandibular Disorders. I: overview and methodology for assessment of validity. J Orofac Pain (2010) 1.67

Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.63

Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain (2011) 1.62

DOMINE: a comprehensive collection of known and predicted domain-domain interactions. Nucleic Acids Res (2010) 1.59

Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Genet (2008) 1.59

Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain (2006) 1.57

Effectiveness of computational methods in haplotype prediction. Hum Genet (2001) 1.53

Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain (2011) 1.52

Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 1.50

Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study. J Pain (2011) 1.50

Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain (2011) 1.48

Influence of nociception and stress-induced antinociception on genetic variation in isoflurane anesthetic potency among mouse strains. Anesthesiology (2005) 1.48

Genetic architecture of human pain perception. Trends Genet (2007) 1.48

Cigarette smoking, stress-induced analgesia and pain perception in men and women. Pain (2005) 1.47

Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.45

Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. Cell Signal (2006) 1.44

Automatic pathway building in biological association networks. BMC Bioinformatics (2006) 1.42

Temporomandibular disorder and comorbid pain conditions. J Am Dent Assoc (2011) 1.40

Draft genome sequence of the rubber tree Hevea brasiliensis. BMC Genomics (2013) 1.35

African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures. Psychosom Med (2005) 1.34

Screening for pain phenotypes: analysis of three congenic mouse strains on a battery of nine nociceptive assays. Pain (2006) 1.34

Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proc Natl Acad Sci U S A (2005) 1.33

Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.32

The feasibility of using mobile-phone based SMS reminders and conditional cash transfers to improve timely immunization in rural Kenya. Vaccine (2012) 1.30

Automatic extraction of gene ontology annotation and its correlation with clusters in protein networks. BMC Bioinformatics (2007) 1.30

Genetic flip-flop without an accompanying change in linkage disequilibrium. Am J Hum Genet (2008) 1.27

Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenet Genomics (2010) 1.25

Reliability, validity, and clinical utility of the research diagnostic criteria for Temporomandibular Disorders Axis II Scales: depression, non-specific physical symptoms, and graded chronic pain. J Orofac Pain (2002) 1.25

A gene expression signature of genetic instability in colon cancer. Cancer Res (2005) 1.23

Associations among four modalities of experimental pain in women. J Pain (2005) 1.22

Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain (2002) 1.21

Reliability and validity of a Swedish version of the Oral Health Impact Profile (OHIP-S). Acta Odontol Scand (2004) 1.21

Adrenergic dysregulation and pain with and without acute beta-blockade in women with fibromyalgia and temporomandibular disorder. J Pain (2009) 1.20